Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
5-azacytidine reverses drug resistance in bladder cancer cells.
Ramachandran K, Gordian E, Singal R.
Anticancer Res. 2011 Nov;31(11):3757-66.
Related citations
Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
Du P, Ye L, Ruge F, Yang Y, Jiang WG.
Anticancer Res. 2011 Oct;31(10):3205-12.
Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review.
Miyata Y, Sagara Y, Matsuo T, Ohba K, Takahashi H, Sakai H, Kanetake H.
Anticancer Res. 2011 Jun;31(6):2335-8.
The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma.
Miyazaki J, Nishiyama H, Yano I, Nakaya A, Kohama H, Kawai K, Joraku A, Nakamura T, Harashima H, Akaza H.
Anticancer Res. 2011 Jun;31(6):2065-71.
Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions.
Vasconcelos-Nóbrega C, Colaço A, Santos L, Vala H, Palomino LF, Lopes C, Oliveira PA.
Anticancer Res. 2011 May;31(5):1637-42.
Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor.
Onishi T, Sasaki T, Hoshina A, Yabana T.
Anticancer Res. 2011 Apr;31(4):1471-4.
15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.
Krause FS, Walter B, Ott OJ, Häberle L, Weiss C, Rödel C, Wullich B, Sauer R.
Anticancer Res. 2011 Mar;31(3):985-90.
Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model.
Hou JC, Landas S, Wang CY, Shapiro O.
Anticancer Res. 2011 Mar;31(3):929-32.
Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2.
Characiejus D, Pasukoniene V, Jacobs JJ, Eidukevicius R, Jankevicius F, Dobrovolskiene N, Mauricas M, Van Moorselaar RJ, Den Otter W.
Anticancer Res. 2011 Feb;31(2):699-703.
The role of pelvic lymph node dissection during radical cystectomy for bladder cancer.
Brunocilla E, Pernetti R, Martorana G.
Anticancer Res. 2011 Jan;31(1):271-5.
CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
Hegele A, Mecklenburg V, Varga Z, Olbert P, Hofmann R, Barth P.
Anticancer Res. 2010 Dec;30(12):5195-200.
Prognostic significance of fluorescent in situ hybridisation in the follow-up of non-muscle-invasive bladder cancer.
Maffezzini M, Campodonico F, Capponi G, Canepa G, Casazza S, Bandelloni R, Tamagno S, Puntoni M.
Anticancer Res. 2010 Nov;30(11):4761-5.
A pilot study of gemcitabine in combination with oxaliplatin and vinorelbine in patients with metastatic bladder cancer.
Pouessel D, Huguet H, Iborra F, Rebillard X, Ayuso D, Becht C, Culine S.
Anticancer Res. 2010 Nov;30(11):4711-5.
Analysis of the cytotoxic activity of carboplatin and gemcitabine combination.
Wang S, Zhang H, Cheng L, Evans C, Pan CX.
Anticancer Res. 2010 Nov;30(11):4573-8.
The antitumour effect of {gamma}{delta} T-cells is enhanced by valproic acid-induced up-regulation of NKG2D ligands.
Suzuki T, Terao S, Acharya B, Naoe M, Yamamoto S, Okamura H, Gotoh A.
Anticancer Res. 2010 Nov;30(11):4509-13.
Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro.
Kato T, Bilim V, Yuuki K, Naito S, Yamanobe T, Nagaoka A, Yano I, Akaza H, Tomita Y.
Anticancer Res. 2010 Oct;30(10):4089-96.
PKCalpha/beta I inhibitor Go6976 induces dephosphorylation of constitutively hyperphosphorylated Rb and G1 arrest in T24 cells.
Aaltonen V, Peltonen J.
Anticancer Res. 2010 Oct;30(10):3995-9.
Combined chemotherapy with gemcitabine and cisplatin for metastatic urothelial carcinomas in patients 80 years of age and over.
Tanji N, Fukumoto T, Miura N, Yanagihara Y, Azuma K, Sasaki T, Nishida T, Kikugawa T, Shimamoto K, Aoki K, Yokoyama M.
Anticancer Res. 2010 Sep;30(9):3839-43.
Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.
Palmieri F, Brunocilla E, Bertaccini A, Guidi M, Pernetti R, Morselli-Labate AM, Martorana G.
Anticancer Res. 2010 Jul;30(7):2973-6.
A3 adenosine receptor antagonist, truncated Thio-Cl-IB-MECA, induces apoptosis in T24 human bladder cancer cells.
Kim H, Kang JW, Lee S, Choi WJ, Jeong LS, Yang Y, Hong JT, Yoon do Y.
Anticancer Res. 2010 Jul;30(7):2823-30.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on